Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)
Key facts
- Who runs it
- Copenhagen Respiratory Research
- Where
- Denmark14 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 1,600 people, planned
- Started
- 10 Mar 2026
- Expected to end
- 1 Nov 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Methylprednisolone (drug)
- hydrocortisone
- Record updated
- 18 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age > 18 years
- Diagnosis of severe CAP for who the physician in charge decides for corticosteroid therapy for severe CAP
Who cannot take part
- Intolerance to either study drug
- Active tuberculosis or fungal infection
- Admitted >24 h
- Pregnant or breastfeeding women
- Pneumonia caused by influenza
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this cluster randomized controlled trial is to determine the optimal treatment for community aquired pneumonia (CAP). The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 18 years old diagnosed with severe CAP. The main question is whether there is a difference in all cause mortality within thirty days.
Read full original descriptionShow less
Participants will be randomized to receive treatment with either hydrocortisone or prednisolone.
The 2 groups in the trial
- Treatment with Hydrocortisone.Existing treatment, for comparison
This arm will recieve a dose of 200 mg of Hydrocortisone intravenously once daily for five days.
Treatment: hydrocortisone
- Treatment with MethylprednisoloneExisting treatment, for comparison
This arm will recieve a dose of 40 mg of Methylprednisolone intravenously once daily for five days.
Treatment: Methylprednisolone (drug)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 18 March 2026